Compare · SYK vs XAGE
SYK vs XAGE
Side-by-side comparison of Stryker Corporation (SYK) and Longevity Health Holdings Inc. (XAGE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SYK and XAGE operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- SYK carries a market cap of $120.60B.
- Over the past year, SYK is down 18.8% and XAGE is down 44.1% - SYK leads by 25.3 points.
- SYK has hit the wire 3 times in the past 4 weeks while XAGE has been quiet.
- SYK has more recent analyst coverage (25 ratings vs 0 for XAGE).
- Company
- Stryker Corporation
- Longevity Health Holdings Inc.
- Price
- $314.56-1.42%
- $2.32-15.02%
- Market cap
- $120.60B
- -
- 1M return
- +2.13%
- +0.00%
- 1Y return
- -18.82%
- -44.10%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 3
- 0
- Recent ratings
- 25
- 0
Stryker Corporation
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Latest SYK
- Stryker expands Mako robotics portfolio with full market release of Mako RPS
- BMO Capital Markets initiated coverage on Stryker with a new price target
- Stryker to announce second quarter 2026 financial results
- Stryker Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Stryker partners with professional golfer Shane Lowry to spotlight the caregiver journey in joint replacement
- Fresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma Firepower
- President and COO Stiles Spencer S gifted 1,607 shares, decreasing direct ownership by 2% to 76,027 units (SEC Form 4)
- Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures
- VP, Chief Legal Officer Fletcher Robert S sold $1,394,409 worth of shares (4,544 units at $306.87) as part of a pre-agreed trading plan, decreasing direct ownership by 30% to 10,582 units (SEC Form 4)
- Director Stryker Ronda E sold $96,792,669 worth of shares (310,000 units at $312.23) (SEC Form 4)
Latest XAGE
- Longevity Health Holdings Inc. filed SEC Form 8-K: Leadership Update
- SEC Form 424B3 filed by Longevity Health Holdings Inc.
- SEC Form SCHEDULE 13D filed by Longevity Health Holdings Inc.
- SEC Form 4 filed by Ajjarapu J. Ram
- SEC Form 3 filed by new insider Ajjarapu J. Ram
- SEC Form 424B3 filed by Longevity Health Holdings Inc.
- SEC Form 10-K filed by Longevity Health Holdings Inc.
- Longevity Health Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Longevity Health Holdings Closes Strategic Investment and Appoints Ram Ajjarapu as Chairman and CEO to Drive Acquisition-Focused Growth
- SEC Form 424B3 filed by Longevity Health Holdings Inc.